WallStreetZenWallStreetZen

NASDAQ: TRAW
Traws Pharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Traws Pharma earnings were -$14.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest TRAW earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$5.7M, up 5.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TRAW reported annual earnings of $6.9M, with -112.6% growth.

TRAW earnings history

Current Revenue
$2.7M
Current Earnings
-$14.8M
Current Profit Margin
-539.7%

TRAW Return on Equity

Current Company
-859.2%
Current Industry
-141.9%
Current Market
13.5%
TRAW's Return on Equity (-859.2%)... subscribe to Premium to read more.
High Return on Equity Performance

TRAW Return on Assets

Current Company
-126%
Current Industry
-13.7%
TRAW is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TRAW announces earnings.

TRAW Return on Capital Employed

Current Company
291.96%
Current Industry
-9.5%
TRAW has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TRAW vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TRAW-$14.65M-$14.75MN/A-$1.71
COCP-$8.77M-$8.83MN/A-$0.73
CYCN-$5.28M-$5.28MN/A-$1.36
JSPR-$53.78M-$55.73MN/A-$2.68
OSRH-$7.28k-$12.49k-100.00%$0.00
View Top Biotech Stocks

Traws Pharma Earnings Reports & History FAQ

What were Traws Pharma's earnings last quarter?

Traws Pharma (NASDAQ: TRAW) reported Q1 2026 earnings per share (EPS) of -$0.53, up 124.42% year over year. Total TRAW earnings for the quarter were -$5.69 million. In the same quarter last year, Traws Pharma's earnings per share (EPS) was $2.17.

If you're new to stock investing, here's how to buy Traws Pharma stock.

Is Traws Pharma profitable or losing money?

As of the last Traws Pharma earnings report, Traws Pharma is currently losing money. Traws Pharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$14.75 million, a 48.32% decrease year over year.

What was TRAW's earnings growth in the past year?

As of Traws Pharma's earnings date in Q2 2026, Traws Pharma's earnings has grown year over year. TRAW earnings in the past year totalled -$14.75 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.